
Your 60-second money minute. Today's topic: Over 65'ers Own The Economy
Loading summary
A
With a CNBC you money minute. I'm Jessica Edinger. While the country is dealing with a weaker labor market, housing affordability and soaring household debt, there's one group that's enjoying the best years of their lives financially.
B
Seniors. Take a look at this headline in the Wall street journal. Over 65, congratulations, you own the economy.
A
That's CNBC's Kelly Evans. The elderly are physically and financially healthier than ever. Here's Kelly with the Wall Street Journal's Greg ip.
C
Take an aging population and you multip it by an epic 40 year boom in asset prices. This is what you get. A massive amount of wealth in the hands of the people who are now retired, which is part of the boring
B
twenties thesis that the boomers are going to have all of this capital, all this, you know, wealth to spend and that's going to support the economy.
A
The problem is the US Isn't replacing its population. People aren't having kids like they used to and the U. S isn't letting people in like it used to. Here's Greg IP with CNBC senior economics reporter Steve Leesman.
C
Their numbers are just not going to be large enough to support all the promises we've made to the elderly. And that again is just the raw arithmetic. Fertility rate keeps dropping. We've clamped down on immigration.
D
We cannot solve this problem without immigration and I think we've made it potentially worse with the immigration rules that will limit the number of people coming in.
A
The full story is in the Wall Street Journal and the full on camera chat is@cnbc.com I'm Jessica Ettinger, CNBC.
E
Snoring, gasping during sleep Feeling fatigued? Wake up to Zeb Bound Terzepat, the first and only FDA approved prescription medicine for moderate to severe obstructive sleep apnea in adults with obesity. Zeb Bound is an injectable prescription medicine that may help adults with moderate to severe obstructive sleep apnea and obesity to improve their osa. Zebound should be used with a reduced calorie diet and increased physical activity. Zebbound is Approved as a 2.5, 5, 7.5, 10, 12.5 or 15 milligram injection. Zetbound contains tirzepatide and should not be used with other Tirzepatide containing products or any GLP1 receptor agonist medicines. It is not known if Zepbound is safe and effective for use in children. Do not share needles or pins or reuse needles. Don't take Zeb Bound if allergic to it or if you or someone in your family had medullary thyroid cancer or multiple endocrine neoplasia Syndrome Type 2. Tell your doctor if you get a lump or swelling in your neck. Stop Zepbound and call your doctor if you have severe stomach pain or a serious allergic reaction. Severe side effects may include inflamed pancreas or gallbladder problems. Tell your doctor if you experience vision changes, depression or suicidal thoughts before scheduled procedures with anesthesia. If you're nursing pregnant, plan to be or taking birth control pills. Taking zepbound with a sulfonylurea or insulin may cause low blood sugar. Side effects include nausea, diarrhea and vomiting, which can cause dehydration and worsen kidney problems. Talk to your doctor, call 1-800-545-5979 or visit zepbound.lilly.com Zepbound and its delivery device, Base and Quickpin are registered trademarks owned or licensed by Eli Lilly and company. Its subsidiaries or affiliates.
Host: Jessica Ettinger, CNBC
Date: March 11, 2026
Episode Duration: 60 seconds (main content: 00:00–01:21)
This short episode of Your Money Minute explores how Americans aged 65 and older currently hold a disproportionate share of the nation’s wealth—shaping the economy in significant ways. Drawing on recent headlines and reporting from The Wall Street Journal, the segment examines why this demographic is thriving, and the demographic and policy challenges that threaten the sustainability of this imbalance.
Jessica Ettinger (Host):
Kelly Evans (CNBC):
Greg Ip (WSJ):
Steve Liesman (CNBC):
This rapid-fire episode underscores a paradox: America’s seniors are wealthier and more secure than ever, even as underlying demographic shifts threaten the economic and social promises made to them. The experts agree—without population growth through immigration or higher birthrates, sustaining this prosperity for future generations will be increasingly difficult.
Further Reading: